Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 118460
AmBisome is a liposomal formulation of amphotericin B. Amphotericin B is a powerful antifungal agent that is well known for its ability to attack and kill a broad variety of life-threatening fungal infections but also has serious side effects, including kidney toxicity.
IPSCIO Record ID: 1645
The Company co-developed and co-promotes AmBisome in the United States.
IPSCIO Record ID: 27375
IPSCIO Record ID: 2734
IPSCIO Record ID: 310523
Amphotericin B is used for the treatment of fungal infections.
The Parties now intend to transfer the technology in the possession of Licensor relating to the manufacture of ABLCÂ®.
By this agreement, Licensor grants an exclusive license to employ Technology for any purpose in the Field and a non-exclusive license for any purpose outside the Field.
Licensor transfers all rights to use ABLCÂ® trademark in connection with the COMPLEX and reserves no rights for itself.
Technology shall mean information relating to COMPLEX which is in the possession of B-MS on December 31, 1992 and patent applications U.S. Serial Nos. 07/876,121 and 08/052,815.
COMPLEX shall mean a liposomal, or lipid-based, formulation of amphotericin B that was under joint development by the parties pursuant to the 1986 Agreement.
Licensee is engaged in the development, manufacture and sale of liposome-and other lipid-based, pharmaceutical products and has developed a lipid-based formulation of the antifungal agent amphotericin B, this agent-lipid complex being generally known as ABLCÂ®.